Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,227,509
-
Total 13F shares
-
81,837,318
-
Share change
-
-7,943,140
-
Total reported value
-
$3,063,093,588
-
Put/Call ratio
-
223%
-
Price per share
-
$37.43
-
Number of holders
-
230
-
Value change
-
-$304,511,458
-
Number of buys
-
126
-
Number of sells
-
97
Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q1 2016
As of 31 Mar 2016,
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) was held by
230 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
81,837,318 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, Capital Research Global Investors, SCOPIA CAPITAL MANAGEMENT LP, VANGUARD GROUP INC, IRIDIAN ASSET MANAGEMENT LLC/CT, D. E. Shaw & Co., Inc., BlackRock Fund Advisors, STATE STREET CORP, RS INVESTMENT MANAGEMENT CO LLC, and FRONTIER CAPITAL MANAGEMENT CO LLC.
This page lists
230
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.